The HemOnc Pulse Live at ASH: Sagar Lonial, MD, FACP, on Role of Transplant, MRD in Myeloma

By Chadi Nabhan, MD, MBA, FACP, Sagar Lonial, MD, FACP - Last Updated: December 14, 2022

The HemOnc Pulse, brought to you by Blood Cancers Today and the Society of Hematologic Oncology, checks in with Blood Cancers Today Editor-in-Chief Sagar Lonial, MD, FACP, during the 64th Annual American Society of Hematology Meeting and Exhibition. Dr. Lonial discussed topics including novel therapies for myeloma, considerations on how to use minimal residual disease data, the current role of transplant, and more, with host Chadi Nabhan, MD, MBA, FACP.

Post Tags:Myeloma ASH 22
Advertisement
Advertisement
Advertisement
Editorial Board